Gilead with a double whammy:
Gilead acquires Ouro Medicines for $1.675 billion, focused on autoimmune diseases with the potential immune-reset drug OM336.
deraktionaer.de/artikel/pharma-biotech/gilead-mit-doppelschlag-20397758.html
Story Details
| Last Updated | |
| Total Articles | 4 |
Main Topics
News on this topic
Barron's Mar 24
Gilead to Buy Ouro Medicines for $2.2 Billion. ‘Immune Reset’ Is Key to Future Gains.
barrons.com/articles/gilead-sciences-stock-ouro-medicines-deal-47750ea5
Paid articlePaywall
Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines: California-based drugmaker takes advantage of surging share price to strike takeovers after a ...
ft.com/content/81528c31-c735-41b7-b042-81a811a76877
Paid articlePaywallSimilar to This
Previous
STAT Oct 19
Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
statnews.com/pharmalot/2026/10/19/roche-investments-in-germany-gilead-bowel-disease-drug/
Paid articlePaywall
Gilead is teaming up with Vir on solid tumor cancer drugs in a deal worth up to $1.9 billion
qz.com/gilead-vir-biotechnology-solid-tumor-cancer-deal-101526
STAT Sep 24
Kyverna’s cell therapy shows lasting autoimmune benefit: Today's biotech news includes FDA adcomm backing Grail's cancer blood test ...
statnews.com/2026/09/24/biotech-news-kyverna-cell-therapy-shows-lasting-autoimmune-benefit/
Paid articlePaywall STAT Sep 24
Why Gilead can’t stop talking about its ambitions in immunology: In this week's edition of "Adam's Biotech Scorecard," Adam also looks ahead ...
statnews.com/2026/09/24/gilead-immunology-inflammation-biotech-moderna-merck/
Paid articlePaywallAppeals court backs Gilead in ruling that threatens overseas prescription drug programs
qz.com/gilead-appeals-court-injunction-overseas-drug-imports-afps-081426
STAT Jun 09
Gilead and Merck’s latest trial success and flop: Today's biotech news includes AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition ...
statnews.com/2026/06/09/biotech-news-gilead-and-merck-latest-trial-success-and-flop/
STAT Apr 08
Terns’ drug may not be as competitive as many initially thought: Today's biotech news covers a controversial class of drugs for Duchenne ...
statnews.com/2026/04/08/biotech-news-terns-drug-may-not-be-as-competitive-as-initially-believed/
Paid articlePaywall Barron's Apr 07
Gilead Adds to Cancer Pipeline With Acquisition Worth Up to $5 Billion: Gilead Sciences agrees to buy German biotech company Tubulis for $3.15 billion upfront ...
barrons.com/articles/gilead-stock-tubulis-acquisition-cancer-32bee850
Paid articlePaywall STAT Apr 07
Gilead to buy cancer biotech Tubulis for more than $3 billion: Tubulis, based in Munich, is developing antibody-drug conjugates, which are next-generation ...
statnews.com/2026/04/07/gilead-sciences-acquisition-tubulis-adcs-chemotherapy-cancer/
Paid articlePaywall For up to $5 billion! Gilead acquires Munich-based biotech company: Gilead Sciences is acquiring the Munich-based biotech company Tubulis for up to $5 billion to ...
deraktionaer.de/artikel/pharma-biotech/fuer-bis-zu-5-milliarden-dollar-gilead-kauft-biotech-firma-aus-muenchen-20398537.html
STAT Mar 31
Psychedelic biotechs face scrutiny over YouTube promos: Today's biotech news covers Biogen and Eli Lilly making takeover moves, Doctors Without Borders ...
statnews.com/2026/03/31/biotech-news-psychedelic-startups-face-scrutiny-over-youtube-promo/
Paid articlePaywall STAT Mar 24
Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more
statnews.com/pharmalot/2026/03/24/trump-drug-pricing-flaw-gilead-buys-ouro/
Paid articlePaywall STAT Mar 24
Gilead to acquire immunology biotech, offers lifeline to Galapagos: Today's biotech news includes Gilead Sciences' acquisition of Ouro ...
statnews.com/2026/03/24/gilead-ouro-galapagos-merck-quotient-ibd-readout-newsletter/
Paid articlePaywall
Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J: Gilead Sciences is buying Arcellx for $7.8 billion. The companies are already working ...
investors.com/news/technology/gilead-sciences-anito-cel-arcellx-acquisition/
South Africa: SA Becomes The First African Country to Register the Twice-a-year Anti-HIV Jab — at Record ...
allafrica.com/stories/202510280170.html
Gilead: Acquisition: Gilead buys biotech company Interius for oncology expansion; expects slight EPS impact.
deraktionaer.de/artikel/pharma-biotech/gilead-uebernahme-20385306.html
Barron's May 23 25
Healthcare Stocks Are So Bad, They’re Good. What to Buy Now.: Healthcare has been running neck and neck with energy and consumer discretionary for the worst ...
barrons.com/articles/healthcare-stocks-what-to-buy-now-7ac23632
Paid articlePaywall Next